This is the official website of IBSA fully dedicated to Business Development, Licensing activities and CDMO projects.
The Business Development Dept. is constantly looking for partners and international distributors for licensing agreements in countries where IBSA does not operate directly with its branches. IBSA is focused on strategic collaborations to achieve a common goal while sharing responsibilities, resources, risks and rewards. Close ties with local distributors are crucial for IBSA to grow at an international level. The Business Development Dept. also evaluates licensing-in opportunities for the expansion of product portfolio.
Discover our productsREAD MORE
Thanks to its consolidated experience, its industrial capacity and its proprietary technologies, IBSA is the ideal partner to serve other companies in the pharmaceutical industry, on a contract basis, providing comprehensive services from drug development through drug manufacturing for EU and non-EU markets.
Discover our technologiesREAD MORE
Product catalogue and brochures
Shaping the future of human possibilities
We are a multinational pharmaceutical company with a specific vision of care that we project from our headquarters in Switzerland to the rest of the world, through a process of on-going expansion in Europe, Asia and North America.READ MORE
DELIVERING INNOVATIVE SOLUTIONS FOR THE NUTRACEUTICAL MARKET
IBSA was established in Lugano in 1945 and started developing its special identity in 1985 when it was acquired by the current ownership, which adopted a new strategy focused on the acquisition of technological resources and launched a development programme aimed at consolidating its global expansion and developing company assets. Today IBSA is present in over 90 countries in 5Read more
IBSA: STRATEGIC LICENSING AND CDMO PROJECTS FOR THE PHARMACEUTICAL MARKET
IBSA will once again be back at CphI Worldwide 2022, Frankfurt, 1-3 November, to present its innovative solutions for the pharmaceutical market, developed in cutting-edge R&D centers and realized in state-of-the art technology production sites.